Abstract:Background: Pregnancy represents a unique challenge for the maternal-fetal immune interface, requiring a balance between immunosuppression, which is essential for the maintenance of a semiallogeneic fetus, and proinflammatory host defense to protect the maternal-fetal interface from invading organisms. Adaptation to repeated inflammatory stimuli (endotoxin tolerance) may be critical in preventing inflammation-induced preterm birth caused by exaggerated maternal inflammatory responses to mild or moderate infections that are common during pregnancy. However, the exact mechanisms contributing to the maintenance of tolerance to repeated infections are not completely understood. MicroRNAs play important roles in pregnancy with several microRNAs implicated in gestational tissue function and in pathologic pregnancy conditions. MicroRNA-519c, a member of the chromosome 19 microRNA cluster, is a human-specific microRNA mainly expressed in the placenta. However, its role in pregnancy is largely unknown. Objective: This study aimed to explore the role of "endotoxin tolerance" failure in the pathogenesis of an exaggerated inflammatory response often seen in inflammation-mediated preterm birth. In this study, we investigated the role of microRNA-519c, a placenta-specific microRNA, as a key regulator of endotoxin tolerance at the maternal-fetal interface. Study design: Using a placental explant culture system, samples from term and second-trimester placentas were treated with lipopolysaccharide. After 24 hours, the conditioned media were collected for analysis, and the placental explants were re-exposed to repeated doses of lipopolysaccharide for 3 days. The supernatant was analyzed for inflammatory markers, the presence of extracellular vesicles, and microRNAs. To study the possible mechanism of action of the microRNAs, we evaluated the phosphodiesterase 3B pathway involved in tumor necrosis factor alpha production using a microRNA mimic and phosphodiesterase 3B small interfering RNA transfection. Finally, we analyzed human placental samples from different gestational ages and from women affected by inflammation-associated pregnancies. Results: Our data showed that repeated exposure of the human placenta to endotoxin challenges induced a tolerant phenotype characterized by decreased tumor necrosis factor alpha and up-regulated interleukin-10 levels. This reaction was mediated by the placenta-specific microRNA-519c packaged within placental extracellular vesicles. Lipopolysaccharide treatment increased the extracellular vesicles that were positive for the exosome tetraspanin markers, namely CD9, CD63, and CD81, and secreted primarily by trophoblasts. Primary human trophoblast cells transfected with a microRNA-519c mimic decreased phosphodiesterase 3B, whereas a lack of phosphodiesterase 3B, achieved by small interfering RNA transfection, led to decreased tumor necrosis factor alpha production. These data support the hypothesis that the anti-inflammatory action of microRNA-519c was mediated by a down-regulation of the phosphodiesterase 3B pathway, leading to inhibition of tumor necrosis factor alpha production. Furthermore, human placentas from normal and inflammation-associated pregnancies demonstrated that a decreased placental microRNA-519c level was linked to infection-induced inflammatory pathologies during pregnancy. Conclusion: We identified microRNA-519c, a human placenta-specific microRNA, as a novel regulator of immune adaptation associated with infection-induced preterm birth at the maternal-fetal interface. Our study serves as a basis for future experiments to explore the potential use of microRNA-519c as a biomarker for infection-induced preterm birth.

Pregnancy tailors endotoxin-induced monocyte and neutrophil responses in the maternal circulation

Placental extracellular vesicles-associated microRNA-519c mediates endotoxin adaptation in pregnancy

The response of the innate immune and cardiovascular systems to LPS in pregnant and nonpregnant mice

LPS-induced maternal inflammation promotes fetal leukocyte recruitment and prenatal organ infiltration in mice

Pregnancy Entails a Metabolic Rewiring of Maternal Circulating Neutrophils

The Effect of Endotoxin on the Intestinal Mucus Layer in Non- and Post-pregnancy Mice

[Effects of pregnancy on the ROS, NO, cytokine levels and lymphocytes activation from mouse peripheral blood]

Integration of transcriptomics and metabolomics reveals the responses of the maternal circulation and maternal-fetal interface to LPS-induced preterm birth in mice

Pregnancy-induced Changes to the Gut Microbiota Drive Macrophage Pyroptosis and Exacerbate Septic Inflammation.

Pregnancy-related factors induce immune tolerance through regulation of sCD83 release

A dynamic peripheral immune landscape during human pregnancy

Anti-inflammatory effects of Placenta-derived exosomal miR-24-1-5p through targeting TNFAIP8 and its implication in enhancing placental endotoxin tolerance in a model of lipopolysaccharide (LPS)-induced placental inflammation

The Local and Systemic Immune Response to Intrauterine LPS in the Prepartum Mouse

Monocytes and macrophages in pregnancy: The good, the bad, and the ugly

The Mechanism of Lipopolysaccharide’s Effect on Secretion of Endometrial Mucins in Female Mice During Pregnancy

Neutrophils induce proangiogenic T cells with a regulatory phenotype in pregnancy

The impact of gut microbiota in full‐term pregnant women on immune regulation during pregnancy: A prospective, exploratory study

LPS-Induced Hypotension in Pregnancy: The Effect of Progesterone Supplementation

Selective exposure of the fetal lung and skin/amnion (but not gastro-intestinal tract) to LPS elicits acute systemic inflammation in fetal sheep

Response of bovine endometrium to interferon tau in the presence of lipopolysaccharide

Role of the Monocyte–Macrophage System in Normal Pregnancy and Preeclampsia